IGF-1 LR3 is a protein, not a peptide, and that changes the analysis

Where the peptide conventions stop working

Most materials in a research catalogue are synthetic chains of five to forty residues, assembled step by step and characterised by chain purity and mass. IGF-1 LR3 is a different kind of object. It is 83 residues, it is produced by recombinant expression rather than solid-phase synthesis, and — decisively — it folds, held in a specific three-dimensional shape by three internal disulfide bonds.

The "LR3" in the name describes two modifications to the parent molecule: an arginine substituted at position three, and a 13-residue extension added at the N-terminus. Both are deliberate, and both are why the material is called an analogue rather than the native protein.

The limitation that matters

Here is the part worth understanding before reading any report for this material: a correctly folded protein and a misfolded one have exactly the same mass and the same amino acid sequence. They differ only in which cysteines are paired and how the chain is arranged in space.

That means an excellent purity figure by HPLC and a matching mass result can both be true of material that has not folded correctly. Neither method is looking at the thing that distinguishes them. This is not a criticism of either technique — it is a statement about what they measure.

Methods that do address folding exist, and a thorough report will reference at least one: size-exclusion chromatography to detect aggregates and multimers, non-reducing versus reducing comparisons to probe whether the disulfides are formed, or a functional assay. What a report should not do is imply that a chain-purity percentage settles the question.

• Aggregation is the characteristic failure. Folded proteins stick to each other, and aggregates are the impurity class to look for rather than deletion sequences.
• Purity conventions differ. Recombinant protein preparations are typically reported at lower purity figures than short synthetic peptides, and that is normal for the class rather than a warning sign.
• Host-derived residuals are plausible here and nowhere else. Material grown in a cell system can carry trace protein or nucleic acid from that system; a synthetic peptide cannot.

See purity versus identity for what each ordinary result does establish.

Storage of the lyophilized solid

Folded proteins are considerably more fragile than short synthetic chains. Beyond the usual temperature and moisture considerations, this class is sensitive to physical stress — agitation and repeated freezing and thawing can drive aggregation without any chemical change to the molecule at all. A lyophilized solid stored cold and sealed is the stable state; the risks begin once it is anything else.

Stability is a documented property rather than an assumed one: a laboratory establishes it by holding material under defined conditions and re-analysing at intervals. Where a retest date is stated, the question worth asking is what data supports it. See storing lyophilized research materials.

Scope of this documentation

This page concerns material identification and analytical documentation for laboratory research. It does not recommend personal, human, clinical, therapeutic or veterinary applications. Published research findings do not establish the properties of Arctic stock; use the applicable lot record and its stated methods and limitations.

Related documentation